Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Translational Lung Cancer Research|July 14, 2022
Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and growIldiko Kovacs, Edina Bugyik, Katalin Dezso, et al.
Cancer Research|January 9, 2020
Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid FeaturesMiriam Marqués, Robin Tranchant, Blanca Risa-Ebrí, et al.
British Journal of Cancer|August 12, 2015
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosisMichaela B Kirschner, Emily Pulford, Mir Alireza Hoda, et al.
Lung Cancer (Amsterdam, Netherlands)|May 6, 2026
Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumorsEvelyn Megyesfalvi, Vivien Teglas, Bence Ferencz, et al.
American Journal of Respiratory and Critical Care Medicine|September 5, 2014
Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapyKarin Schelch, Mir A Hoda, Thomas Klikovits, et al.
The Journal of Pathology|November 19, 2016
Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis modelsVictoria L Bridgeman, Peter B Vermeulen, Shane Foo, et al.
The Journal of Pathology|May 27, 2015
Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesotheliomaViktoria Laszlo, Mir Alireza Hoda, Tamas Garay, et al.
Carcinogenesis|April 11, 2018
FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signalKarin Schelch, Christina Wagner, Sonja Hager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2020
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma SubgroupChristine Pirker, Agnes Bilecz, Michael Grusch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2016
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional studyMir Alireza Hoda, Yawen Dong, Anita Rozsas, et al.
Pageof 9